Radioiodine (131I) therapy of benign thyroid diseases was introduced 70 yr ago, and the
patients treated since then are probably numbered in the millions. Fifty to 90% of …

Simple Summary This year marks the 80th commemoration of the first time that radio-iodide
treatment (RAI) was used. RAI is one of the most effective targeted internal radiation …

Stunning of thyroid tissue by diagnostic activities of 131I has been described by some
investigators and refuted by others. The support both for and against stunning has at times …

Iodine is a key element in the synthesis of thyroid hormones and the process of iodine
transport by thyroid cells is active. Iodine deficiency, which is a known risk factor for thyroid …

Purpose To evaluate the potential of [18 F] fluorodeoxyglucose positron emission
tomography (FDG-PET) for the assessment of histopathological response and survival after …

Context: Published studies of thyroid stunning due to preablation 131I scanning in the
treatment of differentiated thyroid cancer after thyroidectomy had shown inconsistent clinical …

PURPOSE: Systemic therapies when added to whole brain radiotherapy have failed to
improve the survival of patients with multiple brain metastases. The epidermal growth factor …

Purpose Existence and cause of thyroid stunning was controversially discussed for decades
but the underlying mechanism remains unclear. Numerous studies describe thyroid stunning …

Low-energy Auger and conversion electrons deposit their energy in a very small volume (a
few nm3) around the site of emission. From a radiotoxicological point of view the effects of …

Objective Is to investigate possible factors predicting success of ablation for 3700 MBq
radioactive iodine 131 in patients with differentiated thyroid cancer (DTC) following near …